IP Library Granted Patent US 11,499,185
Granted Patent B2
US 11,499,185 · App. 16/046,707 · Granted Nov 15, 2022

Nucleic acid sequencing methods and systems

Inventors: Kandaswamy Vijayan (San Diego, CA); Eugene Tu (San Diego, CA); Mark A. Bernard (Power, CA)
Assignee: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,499,185
App. No.
16/046,707
Granted
Nov 15, 2022
Kind
B2
Abstract

The present disclosure provides compositions, methods and systems for sequencing a template nucleic acid using a polymerase based, nucleic acid binding reaction involving examination of the interaction between a polymerase and template nucleic acid in the presence of one or more unlabeled nucleotides. The methods rely, in part, on identifying a base of a template nucleic acid during nucleic acid synthesis by controlling the sequencing reaction conditions. Template nucleic acid bases may be identified during an examination step followed by an optional incorporation step.

Claims (32)

1. A method of identifying a base in a primed template nucleic acid, comprising

I. performing an examination step comprising:

(a) providing a primed template nucleic acid comprising a primer, wherein the primer comprises a reversible terminator moiety at the 3′ end;

(b) contacting the primed template nucleic acid with a polymerase and a test nucleotide, under conditions that:

(i) stabilize ternary complex formed between the polymerase, primed template nucleic acid and test nucleotide when the test nucleotide is complementary to the next base of the primed template nucleic acid while precluding incorporation of the test nucleotide into the primer, and

(ii) destabilize binary complex formed between the primed template nucleic acid and the polymerase when the test nucleotide is not complementary to the next base of the primed template nucleic acid;

(c) washing to remove any unbound polymerase and unbound nucleotides, wherein the washing occurs under conditions that stabilize the ternary complex;

(d) detecting the ternary complex while precluding incorporation of the test nucleotide into the primer;

(e) identifying the next base of the primed template nucleic acid from the detected ternary complex.

2. The method of claim 1 , wherein the washing comprises contacting the ternary complex with a ternary complex stabilizing agent.

3. The method of claim 1 , further comprising a reloading step, the reloading step comprising contacting the primed template nucleic acid with a polymerase and a nucleotide that is complementary to the next base.

4. The method of claim 3 , further comprising an incorporation step following the reloading step, the incorporation step comprising incorporating into the primer a nucleotide that is complementary to the next base.

5. The method of claim 1 , further comprising an incorporation step, the incorporation step comprising incorporating into the primer a nucleotide that is complementary to the next base.

6. The method of claim 5 , wherein step I. is repeated at least once using a different type of test nucleotide prior to the incorporation step.

7. The method of claim 5 , wherein the nucleotide that is incorporated comprises a reversible terminator moiety.

8. The method of claim 7 , wherein the nucleotide that is incorporated is unlabeled.

9. The method of claim 5 , wherein the incorporation step further comprises replacing the polymerase with a different type of polymerase that catalyzes the incorporation.

10. The method of claim 1 , further comprising an incorporation step, the incorporation step comprising replacing the test nucleotide with a second nucleotide and incorporating the second nucleotide into the primer.

11. The method of claim 10 , wherein the second nucleotide comprises a reversible terminator moiety.

12. The method of claim 11 , wherein the second nucleotide is unlabeled.

13. The method of claim 10 , wherein the incorporation step further comprises replacing the polymerase with a different type of polymerase that catalyzes the incorporation.

14. The method of claim 1 , wherein the conditions comprise presence of a polymerase inhibitor that precludes incorporation of the test nucleotide into the primer.

15. The method of claim 1 , wherein the conditions comprise an amino acid mutation in the polymerase that precludes incorporation of the test nucleotide into the primer.

16. The method of claim 1 , wherein the conditions comprise presence of a reversible terminator on the 3′ end of the primer that precludes incorporation of the test nucleotide into the primer.

17. The method of claim 1 , wherein the test nucleotide comprises a label moiety.

18. The method of claim 1 , further comprising repeating step I. at least once using a second test nucleotide that is different from the test nucleotide.

19. The method of claim 1 , wherein the primed template nucleic acid is attached to a surface.

20. The method of claim 19 , wherein the surface is attached to a clonally amplified population of the primed template nucleic acid.

21. The method of claim 19 , wherein the surface comprises a plurality of different template nucleic acids.

22. The method of claim 1 , wherein the conditions of step (b) comprise presence of a non-catalytic metal ion.

23. The method of claim 1 , wherein the conditions of step (b) comprise presence of salt at a concentration in the range of 50 to 1500 mM.

24. The method of claim 1 , wherein the detecting comprises detecting a change in refractive index, a light scattering signal or a detectable tag.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 059278/0153 →
MERGER Recorded Feb 2, 2022
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 058952/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: VIJAYAN, KANDASWAMY; TU, EUGENE; BERNARD, MARK A.
To: OMNIOME, INC.
Reel/Frame 046645/0372 →
Continuity (2)
Continuation 14805381 · Jul 21, 2015
Related Publication 20190032124A1 · Jan 31, 2019
Cited By (27)
US 12,209,273 US 12,227,796 US 12,258,624 US 12,270,071 US 12,270,074 US 12,275,984 US 12,297,499 US 12,319,956 US 12,325,877 US 12,360,105 US 12,365,944 US 12,400,733 US 12,435,364 US 12,460,251 US 12,509,717 US 12,516,369 US 12,529,096 US 12,553,079 US 12,559,791 US 12,624,390 US 12,662,699 US 12,674,196 US 12,692,484 US 12,703,879 US 12,709,771 US 12,716,092 US 12,718,518